Breaking the Silence: Why Pharma Needs to Speak Up with Brian Reid

🎙️ Real Pharma – Episode Title: Breaking the Silence: Why Pharma Needs to Speak Up
Hosts: Na-Ri Oh & Ian Wendt
Guest: Brian Reid, Founder & Principal at Reid Strategic

In this episode of Real Pharma, Na-Ri and Ian sit down with Brian Reid—a healthcare communicator, strategist, and former journalist who's worked across government, pharma, and media—to explore a provocative question: Why is the pharmaceutical industry so quiet when it comes to telling its own story?

Together, they unpack the communication failures shaping drug pricing, PBMs, the Inflation Reduction Act (IRA), biosimilars, and the broader healthcare system. Brian argues that the problem isn’t a lack of data or platforms—it’s a lack of courage, clarity, and commitment to narrative.

From the importance of speaking up in a noisy media environment to the myth of reputational risk, this conversation is a must-listen for anyone in life sciences, policy, or healthcare storytelling.

• Why pharma’s “default to silence” is damaging public trust—and what the industry can do instead

• The communications trap around complex topics like PBMs, pricing, and benefit design

• How public perception problems could have been avoided with smarter storytelling (hello, Hep C)

• Why simplicity is power—and how “pharm-to-table” and Mark Cuban are reframing the narrative

• The case for overcommunication in the face of misinformation and AI-driven “slop”

• Why the Medicare Prescription Payment Plan was a missed communication opportunity—and how to fix it

“We're in a 30-year experiment of what happens when pharma steps back from the policy debate—and the results are in.” – Brian Reid

“I just want pharma to beat Bigfoot in public trust. That’s my goal.” – Brian Reid

“When in doubt, just shout. Say something. Do something.” – Na-Ri Oh

“It’s not always about having the perfect message—it’s about showing up and making the case.” – Ian Wendt

• Cost Curve – Brian Reid’s daily newsletter on healthcare policy: ReidStrategic.com

• KFF’s piece on complexity as a barrier to affordability

• Examples from Mark Cuban’s Cost Plus Drugs and Eli Lilly CEO Dave Ricks’ public podcast appearances

• 💼 Website: ReidStrategic.com

• 📬 Newsletter: Cost Curve

• 💬 LinkedIn: Brian Reid